{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:30:25Z","timestamp":1770492625463,"version":"3.49.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009431","name":"Humanitas University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The fourth type of multiple endocrine neoplasia (MEN) is known as a rare variant of MEN presenting a MEN1-like phenotype and originating from a germline mutation in CDKN1B. However, due to the small number of cases documented in the literature, the peculiar clinical features of MEN4 are still largely unknown, and clear indications about the clinical management of these patients are currently lacking. In order to widen our knowledge on MEN4 and to better typify the clinical features of this syndrome, we present two more cases of subjects with MEN4, and through a review of the current literature, we provide some possible indications on these patients\u2019 management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Presentation<\/jats:title><jats:p>The first report is about a man who was diagnosed with a metastatic ileal G2-NET at the age of 34. Genetic analysis revealed the mutation p.I119T (c.356T&amp;gt;C) of exon 1 of CDKN1B, a mutation already reported in the literature in association with early-onset pituitary adenomas. The second report is about a 76-year-old woman with a multifocal pancreatic G1-NET. Genetic analysis identified the CDKN1B mutation c.482C&amp;gt;G (p.S161C), described here for the first time in association with MEN4 and currently classified as a variant of uncertain significance. Both patients underwent biochemical and imaging screening for MEN1-related diseases without any pathological findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>According to the cases reported in the literature, hyperparathyroidism is the most common clinical feature of MEN4, followed by pituitary adenoma and neuroendocrine tumors. However, MEN4 appears to be a variant of MEN with milder clinical features and later onset. Therefore, these patients might need a different and personalized approach in clinical management and a peculiar screening and follow-up strategy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.773143","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T10:17:19Z","timestamp":1646821039000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management"],"prefix":"10.3389","volume":"13","author":[{"given":"Elisabetta","family":"Lavezzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Smiroldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"Nappo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Pedicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giampaolo","family":"Trivellin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gherardo","family":"Mazziotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Lania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2796.2009.02108.x","article-title":"Multiple Endocrine Neoplasias: Advances and Challenges for the Future","volume":"266","author":"Alevizaki","year":"2009","journal-title":"J Intern Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-Line Mutations in p27Kip1 Cause a Multiple Endocrine Neoplasia Syndrome in Rats and Humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2008.01.013","article-title":"CDK Inhibitors: Cell Cycle Regulators and Beyond","volume":"14","author":"Besson","year":"2008","journal-title":"Dev Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12881","article-title":"A Cancer-Associated CDKN1B Mutation Induces P27 Phosphorylation on a Novel Residue: A New Mechanism for Tumor Suppressor Loss-of-Function","volume":"15","author":"Bencivenga","year":"2020","journal-title":"Mol Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ccell.2017.07.005","article-title":"Genomic Evolution of Breast Cancer Metastasis and Relapse","volume":"32","author":"Yates","year":"2017","journal-title":"Cancer Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2013.05.029","article-title":"The Mutational Landscape of Prostate Cancer","volume":"64","author":"Barbieri","year":"2013","journal-title":"Eur Urol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-04-643361","article-title":"Recurrent CDKN1B (P27) Mutations in Hairy Cell Leukemia","volume":"126","author":"Dietrich","year":"2015","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0941-6","article-title":"Loss of P27 Expression is Associated With MEN1 Gene Mutations in Sporadic Parathyroid Adenomas","volume":"55","author":"Borsari","year":"2017","journal-title":"Endocrine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B Mutations: The Latest of the MEN Syndromes","volume":"24","author":"Alrezk","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2843","article-title":"Brief Report: Germline CDKN1B\/p27Kip1 Mutation in Multiple Endocrine Neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2083","article-title":"Rare Germline Mutations in Cyclin-Dependent Kinase Inhibitor Genes in Multiple Endocrine Neoplasia Type 1 and Related States","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04269.x","article-title":"Novel Mutations in MEN1, CDKN1B and AIP Genes in Patients With Multiple Endocrine Neoplasia Type 1 Syndrome in Spain","volume":"76","author":"Belar","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/humu.21354","article-title":"A Novel Germline CDKN1B Mutation Causing Multiple Endocrine Tumors: Clinical, Genetic and Functional Characterization","volume":"31","author":"Molatore","year":"2010","journal-title":"Hum Mutat"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1003350","DOI":"10.1371\/journal.pgen.1003350","article-title":"A Novel Mutation in the Upstream Open Reading Frame of the CDKN1B Gene Causes a MEN4 Phenotype","volume":"9","author":"Occhi","year":"2013","journal-title":"PloS Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0080","article-title":"A Heterozygous Frameshift Mutation in Exon 1 of Cdkn1b Gene in a Patient Affected by MEN4 Syndrome","volume":"171","author":"Tonelli","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1338","article-title":"Somatic Mutation and Germline Sequence Abnormalities in CDKN1B, Encoding p27Kip1, in Sporadic Parathyroid Adenomas","volume":"96","author":"Costa-Guda","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-213934","article-title":"Uncommon Association of Cerebral Meningioma, Parathyroid Adenoma and Papillary Thyroid Carcinoma in a Patient Harbouring a Rare Germline Variant in the CDKN1B Gene","volume":"2016","author":"Bugalho","year":"2016","journal-title":"BMJ Case Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12020-015-0540-y","article-title":"Early Onset Acromegaly Associated With a Novel Deletion in CDKN1B 5\u2032UTR Region","volume":"49","author":"Sambugaro","year":"2015","journal-title":"Endocrine"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0929","article-title":"Functional Characterization of a Rare Germline Mutation in the Gene Encoding the Cyclin-Dependent Kinase Inhibitor p27Kip1 (CDKN1B) in a Spanish Patient With Multiple Endocrine Neoplasia-Like Phenotype","volume":"166","author":"Malanga","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1210\/clinem\/dgaa160","article-title":"Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing\u2019s Disease With or Without an MEN4 Phenotype","volume":"105","author":"Chasseloup","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/510985","article-title":"Early Onset Primary Hyperparathyroidism Associated With a Novel Germline Mutation in CDKN1B","volume":"2015","author":"Elston","year":"2015","journal-title":"Case Rep Endocrinol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-11-0362","article-title":"Cyclin-Dependent Kinase Inhibitor 1B(CDKN1B) Gene Variants in AIP Mutation-Negative Familial Isolated Pituitary Adenoma Kindreds","volume":"19","author":"Tichomirowa","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-019-00152-6","article-title":"Co-Occurrence of Multiple Endocrine Neoplasia Type 4 and Spinal Neurofibromatosis: A Case Report","volume":"19","author":"Brock","year":"2020","journal-title":"Fam Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2020.04.002","article-title":"Multiple Endocrine Neoplasia Type 4: Novel CDNK1B Variant and Immune Anomalies","volume":"81","author":"Chevalier","year":"2020","journal-title":"Ann Endocrinol (Paris)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00082","article-title":"Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases","volume":"104","author":"Frederiksen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EC-14-0116","article-title":"Functional Characterization of a CDKN1B Mutation in a Sardinian Kindred With Multiple Endocrine Neoplasia Type 4 (MEN4)","volume":"4","author":"Pardi","year":"2015","journal-title":"Endocr Connect"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1185504","article-title":"p27Kip1 Modulates Cell Migration Through the Regulation of RhoA Activation","volume":"18","author":"Besson","year":"2004","journal-title":"Genes Dev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00468-3","article-title":"Clinical Aspects of Multiple Endocrine Neoplasia Type 1","volume":"17","author":"Al-Salameh","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 Disease Occurring Before 21 Years Old: A 160-Patient Cohort Study From the Groupe D\u2019\u00e9tude Des Tumeurs Endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00393","article-title":"Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors","volume":"9","author":"Cusan","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13010126","article-title":"Mutation of the Cell Cycle Regulator P27KIP1 Drives Pseudohypoxic Pheochromocytoma Development","volume":"13","author":"Mohr","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.773143\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T10:17:23Z","timestamp":1646821043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.773143\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":32,"alternative-id":["10.3389\/fendo.2022.773143"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.773143","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"article-number":"773143"}}